Network origin in Ronald Guido first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 24 | |
Public Company | Pharmaceuticals: Major | 18 | |
Public Company | Pharmaceuticals: Major | 5 | |
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY.
3
| Extinct | Pharmaceuticals: Major | 3 |
Eterna Therapeutics LLC
Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is a clinical-stage biopharmaceutical company based in New York, NY. The company is focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer. Eterna Therapeutics is committed to developing irx-2, a novel cytokine-based therapy, to treat patients with cancer. The active constituents of irx-2, namely interleukin-2 (il-2) and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. Eterna Therapeutics is a late clinical-stage biopharmaceutical company focused on il-2 cytokine-based therapies in treating patients with cancer. Eterna Therapeutics was acquired by NTN Buzztime, Inc. on March 25, 2021 for $213.30 million.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ronald Guido via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
VERICEL CORPORATION | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
MedGenesis Therapeutix, Inc.
MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Chief Executive Officer Founder | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
Sapphire Therapeutics, Inc.
Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member President | |
CHEMOMETEC A/S | Medical Specialties | Director/Board Member | |
PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
NTG NORDIC TRANSPORT GROUP A/S | Trucking | Corporate Officer/Principal | |
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chief Executive Officer | |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | President Corporate Officer/Principal | |
CMC
CMC Miscellaneous Commercial ServicesCommercial Services Part of Universal Music Group NV, CMC is a Danish company that publishes music records. The company is located in Denmark. CMC was acquired by EMI Group Ltd., part of Universal Music Group NV from June 29, 2012 on November 01, 1997. | Miscellaneous Commercial Services | Director/Board Member | |
Bio Products Laboratory Holdings Ltd.
Bio Products Laboratory Holdings Ltd. Medical DistributorsDistribution Services Bio Products Laboratory Holdings Ltd. operates as a holding company with interests in distributing blood plasma products. It operates business through two subsidiaries which include Bio Products Laboratory Ltd. and DCI Biologicals, Inc. The company was founded on 16 October 2002 is headquartered in London, the United Kingdom. | Medical Distributors | Chief Executive Officer | |
Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
Symbion A/S
Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | General Government | Director/Board Member | |
OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
University of Copenhagen | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
7TM A/S
7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
Sophion Bioscience A/S
Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Chairman | |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member Director/Board Member | |
CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Comptroller/Controller/Auditor Corporate Officer/Principal | |
TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Hagemann Ejendomme A/S | Director/Board Member | ||
Yale School of Management | College/University | Masters Business Admin Masters Business Admin | |
Yale School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
University of California Irvine School of Medicine | College/University | Corporate Officer/Principal Director of Finance/CFO | |
EVAXION BIOTECH A/S | Biotechnology | Chairman | |
TERRASCEND CORP. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
Brooklyn Immunotherapeutics Investors LP
Brooklyn Immunotherapeutics Investors LP Financial ConglomeratesFinance Brooklyn Immunotherapeutics Investors LP provides investment services. The company is headquartered in Houston, TX. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
Labrida AS
Labrida AS Medical SpecialtiesHealth Technology Labrida AS provides novel device for maintenance of dental implants. The company was founded by Johan C. Wohlfahrt and Staale Petter Lyngstadaas in August 2012 and is headquartered in Oslo, Norway. | Medical Specialties | Director/Board Member | |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
eGames.com Holdings LLC
eGames.com Holdings LLC Packaged SoftwareTechnology Services eGames.com Holdings LLC operates game publishing business. The company is headquartered in Carson City, NV. | Packaged Software | Chief Executive Officer Director of Finance/CFO |
Statistics
International
United States | 32 |
Denmark | 14 |
Canada | 3 |
Norway | 3 |
United Kingdom | 2 |
Sectoral
Health Technology | 28 |
Consumer Services | 10 |
Technology Services | 3 |
Finance | 3 |
Commercial Services | 3 |
Operational
Director/Board Member | 283 |
Corporate Officer/Principal | 129 |
Independent Dir/Board Member | 89 |
Chief Executive Officer | 72 |
President | 56 |
Most connected contacts
Insiders | |
---|---|
Dennis Langer | 40 |
Luba Greenwood | 32 |
Mette Agger | 30 |
Edward Penhoet | 29 |
Paul Wotton | 27 |
Paul Edick | 27 |
Nicholas Singer | 25 |
Thomas Dyrberg | 24 |
Charles Cherington | 23 |
Michael Heffernan | 23 |
Srinivas Rao | 22 |
Mark Leuchtenberger | 21 |
Walter Ogier | 18 |
Kurt Anker Nielsen | 18 |
Robert Radie | 18 |
- Stock Market
- Insiders
- Ronald Guido
- Company connections